Nurse Practitioner, Family · Hemet, CA
NPI
1356963276
Since 2020
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2569 W Florida Ave # 2569
Hemet, CA, 92545
Phone (519) 253-6359
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.7M
7,419 prescriptions
Company payments, 2025
$997
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Quincy T Woods prescribed most often to Medicare patients was Memantine Hcl, with 630 prescriptions and refills. In total Quincy T Woods wrote 7,419 Medicare prescriptions that cost $1.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Memantine Hcl Generic | 630 | 665 | 85 | $15K |
| Xarelto Rivaroxaban | 428 | 459 | 70 | $234K |
| Quetiapine Fumarate Er Quetiapine Fumarate | 398 | 417 | 69 | $26K |
| Donepezil Hcl Generic | 389 | 427 | 55 | $8,940 |
| Valsartan Generic | 292 | 343 | 53 | $6,706 |
| Duloxetine Hcl Generic | 218 | 219 | 33 | $9,145 |
| Levothyroxine Sodium Generic | 202 | 252 | 32 | $1,822 |
| Divalproex Sodium Generic | 197 | 208 | 34 | $4,332 |
| Atorvastatin Calcium Generic | 185 | 220 | 32 | $1,954 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 173 | 208 | 33 | $4,690 |
| Quetiapine Fumarate Generic | 168 | 178 | 55 | $2,558 |
| Jardiance Empagliflozin | 168 | 179 | 31 | $99K |
| Famotidine Generic | 152 | 203 | 32 | $2,740 |
| Tamsulosin Hcl Generic | 151 | 198 | 26 | $2,142 |
| Gabapentin Generic | 142 | 151 | 20 | $1,471 |
Brand drugs: 1,262 claims; generic drugs: 6,122 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Quincy T Woods $997 ($997 in general payments such as food, travel and fees) from 11 companies. The largest payer was Corcept Therapeutics with $317.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 22 | $317 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 7 | $147 |
| Xeris Pharmaceuticals, Inc. | 5 | $142 |
| Recordati_rare_diseases_inc. | 4 | $117 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $63.3 |
| Abbvie Inc. ABBV | 3 | $63.24 |
| Lundbeck LLC | 2 | $51.25 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $42.9 |
| Baxter Healthcare BAX | 1 | $21.19 |
| Amgen Inc. AMGN | 1 | $17.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.